Boston Scientific has announced its seventh acquisition of 2018, signing an agreement to take over California-based Claret Medical for up to $270 million.
A Woburn-based biotech developing new cancer treatments is planning to spend $20 million to renovate 63,000-square-feet of space in a vacant Framingham building.
Littleton electrical equipment testing lab TUV Rheinland has been accepted into an international organization to test medical and electrical product safety.
Researchers at Worcester Polytechnic Institute have developed a more efficient way to produce a widely used cancer drug by genetically engineering cells from a tree.
Marlborough drugmaker RXi Pharmaceuticals is set to receive nearly $250,000 in grant funds for a collaboration with Cambridge-based BioAxone BioSciences.
Chinese biotech company will build a $60-million facility at the Worcester Biomanufacturing Park, becoming the first tenant at the site of the former Worcester State Hospital.